Not Signed In - Lupin Pharmaceuticals, Inc. Announces Tentative Approval Of Trandolapril Tablets
Wed, 20 Dec 2006 08:00 AM EST
... Lupin Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Trandolapril Tablets, 1mg, 2mg and 4mg. Final approval is expected upon expiry of patent protection for the brand product on June 12, 2007. [click link for full article] ...
Related Topics
- Trandolapril
- Verapamil and Trandolapril
- Carbinoxamine and Pseudoephedrine Tablets
- Vaccine Testing & Approval
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
- Cyanocobalamin Tablets
- Chlorpheniramine, Pseudoephedrine and Hydrocodone Tablets
- Guaifenesin and Dextromethorphan
- Neostigmine Tablets
- Thiabendazole Tablets
- Haloperidol Tablets
- Carbetapentane, Phenylephrine, and Pyrilamine
- Ergoloid Mesylates Sublingual Tablets
- Nystatin Tablets
- Desmopressin Tablets
- Isosorbide Dinitrate, Tablets or Extended-Release Tablets or Capsules
- Tarceva
- Gatifloxacin tablets
- Fenofibrate Tablets
- Verapamil
email this page
print this page
bookmark this page
feedback on this page
